| Theme | Strategy of colon cancer screening | |
|---|---|---|
| Title | Usefulness of simultaneous measurement of fecal lactoferrin and hemoglobin as screening agents for colorectal cancer | |
| Publish Date | 2004/11 | |
| Author | Ichiro Hirata | Internal Medicine II, Osaka Medical College |
| Author | Ryoichi Matsuse | Kyoto Medical Science Laboratory |
| Author | Shingo Yasumoto | Internal Medicine II, Osaka Medical College |
| Author | Osamu Saitoh | lnternal Medicine, Seikeikai Hospital |
| Author | Takashi Nishikawa | Internal Medicine II, Osaka Medical College |
| Author | Mitsuyuki Murano | Internal Medicine II, Osaka Medical College |
| Author | Ken Toshina | Internal Medicine II, Osaka Medical College |
| Author | Kazuo Uchida | Kyoto Medical Science Laboratory |
| Author | Ken-ichi Katsu | Internal Medicine II, Osaka Medical College |
| [ Summary ] | The measurement of fecal lactoferrin levels for colorectal cancer screening was seen to be superior to fecal occult blood tests (FOBT), in terms of the detection of early cancer and cancer in the right side of the colon. In order to improve the sensitivity and specifity of screening tests for colorectal cancer, the simultaneous measurement of fecal lactofernn and hemoglobin was thought to be useful. | |